Corpus Intelligence IC Memo — CCF HOSPITAL - WESTON 2026-04-26 04:01 UTC
IC Memo — CCF HOSPITAL - WESTON
Investment Committee Memorandum | FL | 258 beds | Grade C | EBITDA uplift $34.3M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

CCF HOSPITAL - WESTON

CCN 100289 | BROWARD, FL | 258 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

CCF HOSPITAL - WESTON is a 258-bed suburban community hospital in BROWARD, FL with $465.4M in net patient revenue and a -3.8% operating margin. The hospital serves a payer mix of 26.2% Medicare, 0.8% Medicaid, and 73.0% commercial.

Thesis: Undervalued. Our ML models identify $34.3M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -3.8% to 3.6% (+736bps).

Net Revenue HCRIS$465.4M
Current EBITDA COMPUTED$-17.7M
Operating Margin COMPUTED-3.8%
Occupancy HCRIS86.2%
Revenue / Bed COMPUTED$1.8M
Net-to-Gross HCRIS28.3%
Distress Probability ML38.5%

2. Market Context & Competitive Position

261
FL Hospitals
3.2%
State Median Margin
109
Comparable Hospitals

FL has 261 Medicare-certified hospitals with a median operating margin of 3.2%. The target's margin of -3.8% places it below the state median. Among 109 size-comparable peers (129-516 beds), the median margin is 2.8%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (129-516), prioritizing same-state peers. 109 hospitals in the comp set.

HospitalStateBedsRevenueMargin
CCF HOSPITAL - WESTON (Target)FL258$465.4M-3.8%
MOFFITT CANCER CENTERFL218$1.91B16.0%
MAYO CLINIC FLORIDAFL304$1.09B21.6%
MOUNT SINAI MEDICAL CENTER OF FL481$904.2M12.2%
TALLAHASSEE MEMORIAL HOSPITALFL483$871.6M-4.8%
SHANDS JACKSONVILLE MEDICAL CEFL481$861.4M-7.1%
NICKLAUS CHILDRENS HOSPITALFL259$769.3M5.5%
HCA FLORIDA OCALA HOSPITALFL509$761.7M27.6%
MEMORIAL HOSPITAL WESTFL486$741.4M5.2%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $34.3M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$9.8M+210bp18mo
Cost to Collect4.5%2.5%$9.3M+200bp12mo
Denial Rate Reduction12.0%6.5%$9.2M+198bp12mo
A/R Days Reduction5200.0%3800.0%$5.7M+122bp9mo
Clean Claim Rate88.0%96.0%$298K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$9.8M
Cost to Collect
$9.3M
Denial Rate Reduction
$9.2M
A/R Days Reduction
$5.7M
Clean Claim Rate
$298K
Total EBITDA Uplift$34.3M
Current EBITDA$-17.7M
+ RCM Uplift+$34.3M
Pro Forma EBITDA$16.6M
Current Margin-3.8%
Pro Forma Margin3.6%
WC Released (1x)$17.9M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-27.2M$225.9M0.00x-100.0%
Base (11x exit)10.0x11.0x$-27.2M$239.7M0.00x-100.0%
Bull Case9.0x11.0x$-24.5M$343.9M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-24.5M$368.0M0.00x-100.0%
Bear Case11.0x10.0x$-29.9M$63.5M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-29.9M$60.1M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 109 hospitals with 129-516 beds
  • Same-state prioritization (n=110)
  • Comp margins: P25=-5.2% / P50=2.8% / P75=17.2%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.